English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Tuesday, June 7, 2022
11:18 HKT/SGT
11:17 HKT/SGT
10:17 HKT/SGT
10:16 HKT/SGT
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022
10:15 HKT/SGT
Yew Lee Pacific Group Berhad Debuts at RM0.285 on ACE Market
10:00 HKT/SGT
For Every Special Occasion and Celebration, Yowie Puts the SURPRISE in Party
08:00 HKT/SGT
For Every Special Occasion and Celebration, Yowie Puts the SURPRISE in Party
08:00 HKT/SGT
Novotech助力Endpoints ASCO 2022年專家組,加速中國腫瘤臨床試驗
08:00 HKT/SGT
Novotech助力Endpoints ASCO 2022年专家组,加速中国肿瘤临床试验
08:00 HKT/SGT
Monday, June 6, 2022
18:00 HKT/SGT
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
18:00 HKT/SGT
NFT Association of Hong Kong Officially Launched, Announces Strategic Partnership with TADS Awards
17:50 HKT/SGT
Opening of "Lexus: Sparks of Tomorrow" at the 2022 Milan Design Week
17:23 HKT/SGT
Asian Accountants in Practice to Gather Virtually This Month to Transform Accounting Practices Through Technology
17:00 HKT/SGT
香港非同质化代币协会正式成立并宣布与 TADS 大奖建立战略合作伙伴关系
15:47 HKT/SGT
香港非同質化代幣協會正式成立並宣布與 TADS 大獎建立戰略合作夥伴關係
15:46 HKT/SGT
NEC collaborates with DOCOMO and NTT on 6G experimental trials
15:33 HKT/SGT
NTT DOCOMO and NTT to Collaborate on 6G Experimental Trials with World-leading Mobile Technology Vendors
15:03 HKT/SGT
15:00 HKT/SGT
Fujitsu, NTT DOCOMO and NTT to start joint trials towards practical applications for 6G
14:20 HKT/SGT
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
14:05 HKT/SGT
WRC 第5戦ラリー・イタリア サルディニア デイ4:過酷なグラベルラリーを戦い抜いたロバンペラが総合5位でフィニッシュ
14:00 HKT/SGT
エーザイ、米国臨床腫瘍学会年次総会において抗体薬物複合体farletuzumab ecteribulinの最新の知見を発表
13:00 HKT/SGT
三菱重工、国内初 マイナス25度冷凍倉庫対応レーザー誘導方式無人フォークリフトを共同開発
13:00 HKT/SGT
NEC becomes the first IT service provider to offer a connection point to Microsoft Azure ExpressRoute from its own data center
12:13 HKT/SGT
First In-Person Satellite Industry Forum After COVID Sees the Industry in Strong Shape and Geared for Growth
12:10 HKT/SGT
11:13 HKT/SGT
11:12 HKT/SGT
Ching Lee Holdings Limited (3728.HK) invests HK$24 million to develop To Kwa Wan property project
11:11 HKT/SGT
10:37 HKT/SGT
10:36 HKT/SGT
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure
10:35 HKT/SGT
TOYOTA GAZOO Racing with positives to take from Sardinia
10:25 HKT/SGT
NEC印西データセンターにITベンダーとして初めて「Microsoft Azure ExpressRoute」への接続拠点開設
10:00 HKT/SGT
Sunday, June 5, 2022
Leading visionary AI Leaders to convene in Indonesia to explore the potential of AI and RPA
23:26 HKT/SGT
ESTN Launches World's First Player-Owned Esports Metaverse Arena Featuring Universal Player Ranking Engine
22:40 HKT/SGT
香港中文大学周怡君教授荣获 2022 WIN ADA Award,以表彰其在糖尿病领域的优异研究成果及贡献
09:09 HKT/SGT
香港中文大學周怡君教授榮獲 2022 WIN ADA Award,以表彰其在糖尿病領域的優異研究成果及貢獻
09:08 HKT/SGT
CUHK Professor Elaine Chow Receives "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" for Outstanding Research and Care in Diabetes
09:07 HKT/SGT
Friday, June 3, 2022
Klaytn-based mining NFT 'KlayStore' Starts first minting on June 7th
23:09 HKT/SGT
Klaytn-based mining NFT 'KlayStore' Starts first minting on June 7th
22:00 HKT/SGT
Society Pass (SoPa) Acquires Singapore-based Gorilla Networks, a Next-Gen Blockchain/Web3 Mobile Virtual Network Operator, to Drive SEA's Growing Demand for a New Meta-Economy Experience
20:00 HKT/SGT
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원
20:00 HKT/SGT
三菱重工、インドネシアにおける既設火力発電所向け アンモニア利用発電の事業化調査に着手
18:00 HKT/SGT
 ACN Search:
A Value Model for Responsible Business: The new Value Research Center (VRC) white paper was officially released today. The VRC initiative is aimed at improving company performance and social impact.
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
More events >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575